News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Meda AB (MDABF.PK): Acnex Filed in Europe


4/19/2011 10:47:08 AM

GÖTEBORG, Sweden--(BUSINESS WIRE)-- The marketing authorization application for Acnex (clindamycin with tretinoin) has been submitted to the European regulatory authorities. Acnex is a new product for treatment of mild to severe acne vulgaris. It’s patented and formulated as a once-daily gel. More than 4,000 patients have been included in clinical studies.

Read at BioSpace.com

comments powered by Disqus
Meda AB
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES